Post-vaccine myocarditis against Covid-19 is “mild and rapidly reversible”

Since vaccination against coronavirus in adolescents, a few rare side effects have started to be reported. In the case of vaccines Messenger RNA, What Pfizer and Modern, the myocarditis. Now the Argentinian Society of Cardiology (SAC) took a stand and explained that this pathology, which has a “rate of approximately 12.6 confirmed cases per million seconds of doses”, is “mild and reversing rapidly”, for which she concluded that the benefits of vaccination far outweigh the risks.

In a statement, the SAC explained: “Patients with myocarditis attributable to the Covid-19 vaccination present invariably one or more of these symptoms’:

• Chest pain for two to three days after second dose vaccine.
• High levels of cardiac troponin (peaking about three days later and decreasing over time).
• Very high levels of C-reactive protein, which decrease over time.
• Abnormal electrocardiograms (ECGs).
• Cardiac Magnetic Resonance Imaging Results.

Post-vaccine myocarditis against Covid-19

As the document underlines, the evolution of these clinical pictures, whether they are with or without treatment, “it is soft” and “almost all patients present symptom resolution“As well as” imaging and lab results are improving. “

Either way, they explained that these conditions are treated with nonsteroidal anti-inflammatory drugs, steroids, and colchicine, and even intravenous immunoglobulins, aspirin, beta blockers, and enzyme inhibitors. angiotensin converters can be applied. They also pointed out that during this period, it is “reasonable to restrict vigorous physical activity”.

“Myocarditis and pericarditis are rare events after vaccination against the coronavirus, “said the specialists and pointed out that the cases were detected in people aged 12 to 39, according to estimates published by the Center for Disease Control and Prevention (CDC)

Said in figures, cardiologists assured that, until June 11, in the United States there was 1226 probable case reports of myocarditis or pericarditis after about 300 million doses of mRNA vaccine. “Despite the likely link, mRNA vaccines continue to have a favorable benefit-risk profile and are recommended for people 12 years of age and older,” they noted.

“Vaccination against COVID-19 through available vaccines is today the main means of defense to fight against this pandemic”, they stressed from the SAC and concluded: “Vaccinating the youngest leads to less community transmission which could protect against circulation and the emergence of new variants”.